newsfilter
← Latest News
PR Newswire·

RETA FRAUD ALERT: Jakubowitz Law is Investigating Reata Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws

NEW YORK, June 2, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Reata Pharmaceuticals, Inc. (NASDAQ:RETA) To be